Outset Medical, Inc. (OM)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 15M 30M 45M Q3 '21: 26.3M Q4 '21: 28.2M Q1 '22: 30.6M Q2 '22: 25.1M Q3 '22: 27.8M Q4 '22: 32M Q1 '23: 33.5M Q2 '23: 36M Q3 '23: 30.4M Q4 '23: 30.5M Q1 '24: 28.2M Q2 '24: 27.4M Q3 '24: 28.7M Q4 '24: 29.5M Q1 '25: 29.8M Q2 '25: 31.4M Q3 '25: 29.4M Q4 '25: 28.9M Q1 '26: 27.9M Q2 '26: 31.6M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit Quarterly

0 5M 10M 15M Q3 '21: 2.9M Q4 '21: 3.3M Q1 '22: 4.4M Q2 '22: 3.8M Q3 '22: 4.3M Q4 '22: 5.3M Q1 '23: 6.4M Q2 '23: 7.7M Q3 '23: 7.2M Q4 '23: 7.7M Q1 '24: 8.2M Q2 '24: 9.8M Q3 '24: 9.8M Q4 '24: 10.7M Q1 '25: 11.1M Q2 '25: 11.9M Q3 '25: 11.6M Q4 '25: 12.2M Q1 '26: 12.1M Q2 '26: 13.3M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Income Quarterly

-60M -40M -20M 0 20M 40M 60M Q3 '21: -30.1M Q4 '21: -40.8M Q1 '22: -36.5M Q2 '22: -43.7M Q3 '22: -41M Q4 '22: -39.8M Q1 '23: -43.5M Q2 '23: -43.5M Q3 '23: -45.5M Q4 '23: -37.4M Q1 '24: -36.9M Q2 '24: -30.8M Q3 '24: -23.8M Q4 '24: -21.9M Q1 '25: -16.4M Q2 '25: -16.9M Q3 '25: -15.8M Q4 '25: -17.6M Q1 '26: -16.9M Q2 '26: -15.7M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income Quarterly

-60M -40M -20M 0 20M 40M 60M Q3 '21: -30.5M Q4 '21: -41.2M Q1 '22: -36.9M Q2 '22: -43.8M Q3 '22: -40.8M Q4 '22: -41.4M Q1 '23: -44M Q2 '23: -44M Q3 '23: -46.2M Q4 '23: -38.6M Q1 '24: -39.9M Q2 '24: -34.5M Q3 '24: -27.9M Q4 '24: -25.6M Q1 '25: -25.8M Q2 '25: -18.5M Q3 '25: -17.8M Q4 '25: -19.5M Q1 '26: -19M Q2 '26: -18M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue Quarterly

0 10M 20M 30M Q3 '21: 23.4M Q4 '21: 24.8M Q1 '22: 26.1M Q2 '22: 21.3M Q3 '22: 23.4M Q4 '22: 26.7M Q1 '23: 27M Q2 '23: 28.3M Q3 '23: 23.2M Q4 '23: 22.8M Q1 '24: 20M Q2 '24: 17.6M Q3 '24: 18.8M Q4 '24: 18.7M Q1 '25: 18.7M Q2 '25: 19.6M Q3 '25: 17.8M Q4 '25: 16.6M Q1 '26: 15.8M Q2 '26: 18.4M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow Quarterly

-60M -40M -20M 0 20M 40M 60M Q3 '21: -28.1M Q4 '21: -32.7M Q1 '22: -38.3M Q2 '22: -38.6M Q3 '22: -34.3M Q4 '22: -34.5M Q1 '23: -44.8M Q2 '23: -28.2M Q3 '23: -34M Q4 '23: -24.4M Q1 '24: -45.9M Q2 '24: -33.3M Q3 '24: -20.6M Q4 '24: -16.5M Q1 '25: -25.7M Q2 '25: -4.8M Q3 '25: -6.3M Q4 '25: -9.5M Q1 '26: -12.8M Q2 '26: -9.6M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow Quarterly

-60M -40M -20M 0 20M 40M 60M Q3 '21: -28.6M Q4 '21: -33.5M Q1 '22: -39.8M Q2 '22: -40.6M Q3 '22: -37.1M Q4 '22: -36.6M Q1 '23: -45.6M Q2 '23: -29M Q3 '23: -34.8M Q4 '23: -25.5M Q1 '24: -46.3M Q2 '24: -33.5M Q3 '24: -21M Q4 '24: -16.5M Q1 '25: -25.8M Q2 '25: -5.1M Q3 '25: -6.5M Q4 '25: -9.7M Q1 '26: -12.9M Q2 '26: -9.7M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 15M 30M 45M Q1 '20: 5.6M Q1 '21: 42.8M Q2 '21: 45.7K Q3 '21: 46.6K Q1 '22: 47.5K Q2 '22: 47.9K Q3 '22: 48.1K Q1 '23: 48.8K Q2 '23: 49K Q3 '23: 49.9K Q1 '24: 3.4K Q2 '24: 3.5K Q3 '24: 3.5K Q1 '25: 7K Q2 '25: 17.7K Q3 '25: 17.8K Q1 '26: 18.4K Q2 '26: 18.6K Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-105.00 -70.00 -35.00 0.00 35.00 70.00 105.00 Q4 '19: -89.38 Q1 '21: -9.47 Q4 '19 Q1 '21

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.